Colitis - 174 Studies Found Completed : Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients : Colitis, Ulcerative : 2011-01-25 : Biological: Anrukinzumab 200 m Active, not recruiting : A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis : Colitis, Ulcerative : 2013-07-12 : Drug: Golimumab Golimumab will be administered subcutaneously. For participants weighing less than 45 kg Completed : The Efficacy and Safety of Kappaproct in Chronic Active Treatment Refractory Ulcerative Colitis Patients : Colitis, Ulcerative : 2011-12-12 : Drug: Kappaproct 30 mg rectal Recruiting : GSK2982772 Study in Ulcerative Colitis Patients : Colitis, Ulcerative : 2016-09-13 : Drug: GSK2982772 GSK2982772 is Enrolling by invitation : Necrotizing Enterocolitis (NEC) Surgical Database : Necrotizing Enterocolitis : 2005-06-30 Completed : Infloran® for Prevention of Necrotizing Enterocolitis : Necrotizing Enterocolitis : 2012-12-14 Recruiting : Clostridium and Neonatal Necrotizing Enterocolitis Pathophysiology : Clinical and Molecular Approaches : Necrotizing Enterocolitis : 2015-02-16 Recruiting : Simulated Amniotic Fluid In Preventing Feeding Intolerance and Necrotizing Enterocolitis VLBW Neonates : Necrotizing Enterocolitis : 2015-02-23 : Drug: simulated amniotic fluid 20cc/kg/day enterally Enrolling by invitation : Enteral Administration of Docosahexaenoic Acid to Prevent Necrotizing Enterocolitis in Preterm Neonates : Necrotizing Enterocolitis : 2012-11-23 : Dietary Supplement: Docosahexaenoic acid (DHA) Completed : Comparison of Two Surgical Treatments for Necrotizing Enterocolitis in Human Infants : Necrotizing Enterocolitis : 2005-11-09 : Procedure: laparotomy Procedure: primary p <<< Previous | Next >>>
